These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25549156)

  • 1. Olfactory neurons obtained through nasal biopsy combined with laser-capture microdissection: a potential approach to study treatment response in mental disorders.
    Narayan S; McLean C; Sawa A; Lin SY; Rai N; Hipolito MS; Cascella N; Nurnberger JJ; Ishizuka K; Nwulia EA
    J Vis Exp; 2014 Dec; (94):. PubMed ID: 25549156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium-associated transcriptional regulation of CRMP1 in patient-derived olfactory neurons and symptom changes in bipolar disorder.
    McLean CK; Narayan S; Lin SY; Rai N; Chung Y; Hipolito MS; Cascella NG; Nurnberger JI; Ishizuka K; Sawa AS; Nwulia EA
    Transl Psychiatry; 2018 Apr; 8(1):81. PubMed ID: 29666369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant intracellular calcium signaling in olfactory neurons from patients with bipolar disorder.
    Hahn CG; Gomez G; Restrepo D; Friedman E; Josiassen R; Pribitkin EA; Lowry LD; Gallop RJ; Rawson NE
    Am J Psychiatry; 2005 Mar; 162(3):616-8. PubMed ID: 15741484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular models to study bipolar disorder: A systematic review.
    Viswanath B; Jose SP; Squassina A; Thirthalli J; Purushottam M; Mukherjee O; Vladimirov V; Patrinos GP; Del Zompo M; Jain S
    J Affect Disord; 2015 Sep; 184():36-50. PubMed ID: 26070045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential mechanisms of action of lithium in bipolar disorder. Current understanding.
    Malhi GS; Tanious M; Das P; Coulston CM; Berk M
    CNS Drugs; 2013 Feb; 27(2):135-53. PubMed ID: 23371914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.
    Machado-Vieira R; Manji HK; Zarate CA
    Bipolar Disord; 2009 Jun; 11 Suppl 2(Suppl 2):92-109. PubMed ID: 19538689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression.
    Nugent AC; Carlson PJ; Bain EE; Eckelman W; Herscovitch P; Manji H; Zarate CA; Drevets WC
    J Psychopharmacol; 2013 Oct; 27(10):894-902. PubMed ID: 23926239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response.
    Hajek T; Bauer M; Simhandl C; Rybakowski J; O'Donovan C; Pfennig A; König B; Suwalska A; Yucel K; Uher R; Young LT; MacQueen G; Alda M
    Psychol Med; 2014 Feb; 44(3):507-17. PubMed ID: 23721695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mRNA expression of peripheral glial cell markers in bipolar disorder: The effect of long-term lithium treatment.
    Ferensztajn-Rochowiak E; Tarnowski M; Samochowiec J; Michalak M; Ratajczak MZ; Rybakowski JK
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1516-1521. PubMed ID: 27474686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study.
    Machado-Vieira R; Zanetti MV; Otaduy MC; De Sousa RT; Soeiro-de-Souza MG; Costa AC; Carvalho AF; Leite CC; Busatto GF; Zarate CA; Gattaz WF
    J Clin Psychopharmacol; 2017 Feb; 37(1):40-45. PubMed ID: 27902528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lithium treatment alters the excitatory/ inhibitory balance of synaptic networks and reduces mGluR5-PKC signalling in mouse cortical neurons.
    Khayachi A; Ase A; Liao C; Kamesh A; Kuhlmann N; Schorova L; Chaumette B; Dion P; Alda M; Séguéla P; Rouleau G; Milnerwood A
    J Psychiatry Neurosci; 2021 Jun; 46(3):E402-E414. PubMed ID: 34077150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
    Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
    BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring lithium's transcriptional mechanisms of action in bipolar disorder: a multi-step study.
    Akkouh IA; Skrede S; Holmgren A; Ersland KM; Hansson L; Bahrami S; Andreassen OA; Steen VM; Djurovic S; Hughes T
    Neuropsychopharmacology; 2020 May; 45(6):947-955. PubMed ID: 31652432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium's clinical efficacy.
    Milanesi E; Voinsky I; Hadar A; Srouji A; Maj C; Shekhtman T; Gershovits M; Gilad S; Chillotti C; Squassina A; Potash JB; Schulze TG; Goes FS; Zandi P; Kelsoe JR; Gurwitz D
    World J Biol Psychiatry; 2019 Jul; 20(6):449-461. PubMed ID: 28854847
    [No Abstract]   [Full Text] [Related]  

  • 16. The microtubular cytoskeleton of olfactory neurons derived from patients with schizophrenia or with bipolar disorder: Implications for biomarker characterization, neuronal physiology and pharmacological screening.
    Benítez-King G; Valdés-Tovar M; Trueta C; Galván-Arrieta T; Argueta J; Alarcón S; Lora-Castellanos A; Solís-Chagoyán H
    Mol Cell Neurosci; 2016 Jun; 73():84-95. PubMed ID: 26837043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients.
    Squassina A; Pisanu C; Congiu D; Caria P; Frau D; Niola P; Melis C; Baggiani G; Lopez JP; Cruceanu C; Turecki G; Severino G; Bocchetta A; Vanni R; Chillotti C; Del Zompo M
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1241-7. PubMed ID: 27084304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium treatment impacts nucleus accumbens shape in bipolar disorder.
    Vecchio D; Piras F; Piras F; Banaj N; Janiri D; Simonetti A; Sani G; Spalletta G
    Neuroimage Clin; 2020; 25():102167. PubMed ID: 31972398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole blood transcriptome analysis in bipolar disorder reveals strong lithium effect.
    Krebs CE; Ori APS; Vreeker A; Wu T; Cantor RM; Boks MPM; Kahn RS; Olde Loohuis LM; Ophoff RA
    Psychol Med; 2020 Nov; 50(15):2575-2586. PubMed ID: 31589133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium-induced gene expression alterations in two peripheral cell models of bipolar disorder.
    Kittel-Schneider S; Hilscher M; Scholz CJ; Weber H; Grünewald L; Schwarz R; Chiocchetti AG; Reif A
    World J Biol Psychiatry; 2019 Jul; 20(6):462-475. PubMed ID: 29067888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.